As the Vice President, Drug Safety and Pharmacovigilance at Biorasi, Mark develops policies, methodologies tools and templates to manage the branch within the organization. Mark has practiced Pharmacy for approximately 18 years in both the hospital and retail settings. His experience within the pharmaceutical industry includes Parke-Davis/Warner-Lambert, Pfizer Pharmaceuticals, and at Regeneron Pharmaceuticals. Mark also became a known presenter and lecturer at DIA conferences (chairing multiple meetings) on Drug Safety and conducted training sessions over the years involving MedDRA and the WHO Drug Dictionary.

Eric Smith, PharmD is currently a Senior Director, Safety Evaluation and Risk Management (SERM) at TESARO, A GSK Company where he provides scientific expertise in the safety evaluation and risk management of key assets in clinical development and the post-marketing setting. Prior to this current position, he worked over 25 years in the pharmaceutical industry and served as a Pharmacovigilance Science Director at AstraZeneca and a Director and Safety Development Leader within the SERM group of the Global Clinical Safety and Pharmacovigilance department at GlaxoSmithKline. Eric earned his Bachelor of Science and Doctor of Pharmacy degrees from the University of North Carolina at Chapel Hill.